Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.365
Delayed Data
As of 12:50pm ET
 -0.01 / -2.67%
Today’s Change
0.08
Today|||52-Week Range
0.45
+224.44%
Year-to-Date
2 Reasons Why Alnylam Pharmaceuticals Stock Gained 18.5% in November
Dec 07 / MotleyFool.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals, Inc. Jumped 9.4% in November
Dec 05 / MotleyFool.com - Paid Partner Content
Actelion is a Perfect Fit for Sanofi but Probably too Expensive: Exane BNP
Dec 07 / TheStreet.com - Paid Partner Content
Alnylam Reports Positive Data on Fitusiran, Givosiran
Dec 05 / Zacks.com - Paid Partner Content
Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion
Dec 07 / MotleyFool.com - Paid Partner Content
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov 30 / Zacks.com - Paid Partner Content
Novo Nordisk Files Regulatory Application for Semaglutide
Dec 06 / Zacks.com - Paid Partner Content
NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted...
Nov 30 / Zacks.com - Paid Partner Content
Better Buy: MannKind Corp. vs. Novo Nordisk
Dec 06 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: UnitedHealth, 21st Century Fox, Sanofi, MasterCard...
Nov 30 / Zacks.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Tuesday
Dec 06 / TheStreet.com - Paid Partner Content
Top Research Reports for 29th November, 2016
Nov 29 / Zacks.com - Paid Partner Content
Actelion Surges on Report of Sanofi Challenge to J&J Takeover Bid
Dec 06 / TheStreet.com - Paid Partner Content
Celgene vs. Regeneron: Which Stock is a Better Pick?
Nov 29 / Zacks.com - Paid Partner Content
European Stocks Slip Lower, Italy Gains in Mixed Start to Trading
Dec 06 / TheStreet.com - Paid Partner Content
Drug and biotech stocks soar on Trump victory
Nov 09 / CNNMoney.com